Lobbying disclosures · Lobbying report
HUM: third_quarter 2026 lobbying report
Medicare Advantage (MA) Policy and Reimbursement Medicare Part D Issues Medicaid Policy Issues Including Dual Eligibles Pharmacy Benefit Managers (PBM) and Pharmacy Policy and Reimbursement Issues Home Health Policy and Reimbursement Issues Implementation of Inflation Reduction Act of 2022 Public Law No. 117-169 H.R. 3514/S.1816, Improving Seniors' Timely Access to Care Act of 2025 (119th Congress) Prior Authorization Policy and Regulatory Issues CMS-4185-F2 Medicare Advantage Risk Adjustment Data Validation Final Rule Primary Care and Value-Based Care Policy and Reimbursement Clinical Policy
Follow HUM- Became public
- Oct 19, 2026, 3:28 PM EDT
- Event / period date
- Not stated
- Collected
- Nov 11, 2026, 9:29 AM EST
Why this is connected
Exact legal-name match: HUMANA INC (https://www.sec.gov/Archives/edgar/data/49071/).
Reported lobbying amounts
Expenses: $1,520,000.00
These are different reporting measures. They are not added together or treated as spending on one particular bill.
Source evidence
Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/a4a1698f-d62f-477c-b7bc-9859f0e60673/","filing_uuid":"a4a1698f-d62f-477c-b7bc-9859f0e60673","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/a4a1698f-d62f-477c-b7bc-9859f0e60673/print/","filing_document_content_type":"text/html","income":null,"expenses":"1520000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Michelle Espinal","dt_posted":"2026-10-19T15:28:17-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"101 E Main Street","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"LOUISVILLE","registrant_state":"KY","registrant_zip":"40202","registrant":{"id":18912,"url":"https://lda.gov/api/v1/registrants/18912/","house_registrant_id":32289,"name":"HUMANA, INC.","description":null,"address_1":"101 E Main Street","address_2":null,"address_3":null,"address_4":null,"city":"LOUISVILLE","state":"KY","state_display":"Kentucky","zip":"40202","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MICHELLE ESPINAL","contact_telephone":"+1 407-922-7166","dt_updated":"2026-07-30T15:25:39.453098-04:00"},"client":{"id":125923,"url":"https://lda.gov/api/v1/clients/125923/","client_id":12,"name":"HUMANA INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"KY","state_display":"Kentucky","country":"US","country_display":"United States of America","ppb_state":"KY","ppb_state_display":"Kentucky","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Medicare Advantage (MA) Policy and Reimbursement Medicare Part D Issues Medicaid Policy Issues Including Dual Eligibles Pharmacy Benefit Managers (PBM) and Pharmacy Policy and Reimbursement Issues Home Health Policy and Reimbursement Issues Implementation of Inflation Reduction Act of 2022 Public Law No. 117-169 H.R. 3514/S.1816, Improving Seniors' Timely Access to Care Act of 2025 (119th Congress) Prior Authorization Policy and Regulatory Issues CMS-4185-F2 Medicare Advantage Risk Adjustment Data Validation Final Rule Primary Care and Value-Based Care Policy and Reimbursement Clinical Policy Issues Including Workforce and Mental Health Hospital Outpatient Prospective Payment System (OPPS): Remedy for the 340B-Acquired Drug Payment Policy for Calendar Years 2018-2022 Final Rule (CMS 1793-F) Implementation of CMS Interoperability and Prior Authorization final rule (CMS-0057-F) Contract Year 2025 Medicare Advantage and Part D Final Rule (CMS-4205-F) Announcement of Calendar Year (CY) 2025 Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies Final Calendar Year (CY) 2025 Part D Redesign Program Instructions PL 119-21, One Big Beautiful Bill Act S.1105, No Unreasonable Payments, Coding, or Diagnoses for the Elderly Act H.R. 3467, Medicare Advantage Reform Act Policy issues related to VA-eligible Medicare beneficiaries Final Calendar Year (CY) 2026 Part D Redesign Program Instructions Contract Year 2026 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly (CMS-4208-F) Final Guidance for Medicare Drug Price Negotiation Program guidance for initial price applicability year 2028 CMS Health Tech Ecosystem initiative H.R. 1732, GUARD VA Benefits Act H.R. 5454/S. 2789, Medicare Advantage Prompt Pay Act Contract Year 2027 Medicare Advantage and Part D Final Rule (CMS-4208-F3/CMS-4212-F) Calendar Year (CY) 2027 Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies (the CY 2027 Rate Announcement) 2026 CMS Interoperability Standards and Prior Authorization for Drugs Proposed Rule (CMS-0062-P) Medicare Drug Price Negotiation Program Proposed Rule (CMS-4215-P) Healthcare cybersecurity and Artificial Intelligence (AI) policy issues Request for Information (RFI): Pharmacy Benefit Manager Compensation and Data Collection (CMS-4218-NC) Consolidated Appropriations Act of 2026 Fiscal Year 2027 Hospice Wage Index and Payment Rate Update and Hospice Quality Reporting Program Requirements Final Rule (CMS-1851-F) Fiscal Year 2027 Skilled Nursing Facility Prospective Payment System Final Rule (CMS 1843-F) Manufacturer Effectuation of MFP Draft Guidance for 2028 Medicare Drug Price Negotiation Calendar Year (CY) 2027 Medicare Physician Fee Schedule Proposed Rule (CMS-1848-P) Calendar Year (CY) 2027 Home Health Prospective Payment System Proposed Rule (CMS-1844-P) Request for Information (RFI): Medicare Part D Reasonable and Relevant Pharmacy Contracting Standards (CMS-4217-NC)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":146188,"prefix":null,"prefix_display":null,"first_name":"TIFFANY","nickname":null,"middle_name":null,"last_name":"HAVERLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149512,"prefix":null,"prefix_display":null,"first_name":"KAITLYN","nickname":null,"middle_name":null,"last_name":"LANE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":155477,"prefix":null,"prefix_display":null,"first_name":"CROZER","nickname":null,"middle_name":null,"last_name":"CONNOR","suffix":null,"suffix_display":null},"covered_position":"Rep. Mike Thompson, Staff Assistant(2015-2016); Rep. Mike Thompson, Leg. Correspondent(2016-2017); Rep. Mike Thompson, Leg. Assistant (2017-2020); Rep. Mike Thompson, Senior Policy Advisor(2020-2022); Rep. Mike Thompson, Leg. Director(2022-2024)","new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"TRICARE Policy Issues including Telehealth, Value-Based Care, and T-5 Transition NDAA Implementation Policy Issues Veterans' Healthcare and Policy Issues H.R. 8800/S.4784: National Defense Authorization Act for Fiscal Year 2027","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":146188,"prefix":null,"prefix_display":null,"first_name":"TIFFANY","nickname":null,"middle_name":null,"last_name":"HAVERLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149512,"prefix":null,"prefix_display":null,"first_name":"KAITLYN","nickname":null,"middle_name":null,"last_name":"LANE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":155477,"prefix":null,"prefix_display":null,"first_name":"CROZER","nickname":null,"middle_name":null,"last_name":"CONNOR","suffix":null,"suffix_display":null},"covered_position":"Rep. Mike Thompson, Staff Assistant(2015-2016); Rep. Mike Thompson, Leg. Correspondent(2016-2017); Rep. Mike Thompson, Leg. Assistant (2017-2020); Rep. Mike Thompson, Senior Policy Advisor(2020-2022); Rep. Mike Thompson, Leg. Director(2022-2024)","new":true}],"government_entities":[{"id":25,"name":"Defense, Dept of (DOD)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Tax Reform Implementation Issues PL 119-21, One Big Beautiful Bill Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":146188,"prefix":null,"prefix_display":null,"first_name":"TIFFANY","nickname":null,"middle_name":null,"last_name":"HAVERLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149512,"prefix":null,"prefix_display":null,"first_name":"KAITLYN","nickname":null,"middle_name":null,"last_name":"LANE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":155477,"prefix":null,"prefix_display":null,"first_name":"CROZER","nickname":null,"middle_name":null,"last_name":"CONNOR","suffix":null,"suffix_display":null},"covered_position":"Rep. Mike Thompson, Staff Assistant(2015-2016); Rep. Mike Thompson, Leg. Correspondent(2016-2017); Rep. Mike Thompson, Leg. Assistant (2017-2020); Rep. Mike Thompson, Senior Policy Advisor(2020-2022); Rep. Mike Thompson, Leg. Director(2022-2024)","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Prescription drug pricing Pharmacy Benefit Managers (PBM) and Pharmacy Policy and Reimbursement Issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":146188,"prefix":null,"prefix_display":null,"first_name":"TIFFANY","nickname":null,"middle_name":null,"last_name":"HAVERLY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149512,"prefix":null,"prefix_display":null,"first_name":"KAITLYN","nickname":null,"middle_name":null,"last_name":"LANE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":155477,"prefix":null,"prefix_display":null,"first_name":"CROZER","nickname":null,"middle_name":null,"last_name":"CONNOR","suffix":null,"suffix_display":null},"covered_position":"Rep. Mike Thompson, Staff Assistant(2015-2016); Rep. Mike Thompson, Leg. Correspondent(2016-2017); Rep. Mike Thompson, Leg. Assistant (2017-2020); Rep. Mike Thompson, Senior Policy Advisor(2020-2022); Rep. Mike Thompson, Leg. Director(2022-2024)","new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}Congressional trading in HUM
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Nov 5, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Oct 13, 2026 · disclosed Nov 5, 2026 · Dependent
- Jul 21, 2026$1K–$15K
Sen. Alan Armstrong (R-OK)
$1K–$15K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP - Mar 12, 2026$1K–$15K
Rep. Julia Letlow (R-LA-5)
$1K–$15K · Traded Feb 10, 2026 · disclosed Mar 12, 2026
Got $12K from the company’s PAC - Feb 6, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Jan 29, 2026 · disclosed Feb 6, 2026 · Spouse
- Jan 13, 2026$1K–$15K
Rep. Julia Letlow (R-LA-5)
$1K–$15K · Traded Aug 8, 2025 · disclosed Jan 13, 2026 · filed 158 days later
Got $12K from the company’s PAC - Dec 15, 2025$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
$1K–$15K · Traded Nov 12, 2025 · disclosed Dec 15, 2025
- Nov 21, 2025$1K–$15K
Rep. Lisa C. McClain (R-MI-9)
$1K–$15K · Traded Oct 31, 2025 · disclosed Nov 21, 2025 · Spouse
Got $1K from the company’s PAC - Nov 21, 2025$1K–$15K
Rep. Lisa C. McClain (R-MI-9)
$1K–$15K · Traded Oct 30, 2025 · disclosed Nov 21, 2025 · Spouse
Got $1K from the company’s PAC
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.